SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation Worth US$61 Million Under Botulism Antitoxin Supply Contract